Enalapril Maleate Tablets, USP; 10 mg; 90 tablets, NDC 60429-185-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA.
Check against the official notice below — it lists the full affected range.
Golden State Medical Supply Inc. is recalling Enalapril Maleate Tablets, USP 10 mg in bottles of 90 tablets due to Current Good Manufacturing Practice (CGMP) deviations. The recall affects 31,260 bottles distributed nationwide across Pennsylvania, Massachusetts, Ohio, Texas, Illinois, North Dakota, and Hawaii. The affected product was manufactured by Taro Pharmaceutical Industries, Ltd. and packaged by GSMS, Incorporated in California, with multiple lot numbers and expiration dates ranging from April 2022 through May 2024 (NDC 60429-185-90).
The source document does not specify a remedy or what affected consumers should do in response to this recall.
Written by software from the official notice below. Not reviewed by a lawyer.
CGMP Deviations
Reason for recall: CGMP Deviations Distribution: Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI Quantity: 31,260 bottles Lot/code info: Lots: GS027890, GS028177, GS028488, 10 mg; 90 tablets, Exp.: 04/2022; Lots: GS028847, GS028848, Exp.: 09/2022; GS029627, GS029862,GS030057, GS030481, GS030870, GS031060, GS031437, GS031438, GS033527, GS034231, Exp.: 10/2022; Lots: GS034810, Exp.: 01/2023; Lots: GS035240, GS035598, Exp.: 05/2023; Lots: GS036194, Exp.: 06/2023; Lots: GS036760, GS036981,GS037526, GS038177, GS038728, Exp.: 08/2023; Lots: GS038729, GS041108, Exp.: 09/2023; Lots: GS039412, GS039840, GS041109, Exp.: 12/2023; Lot: GS041655, Exp.: 01/2024; Lot: GS041656, Exp.: 05/2024. (NDC: 60429-185-90).
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.